International Agencies

This document contains an overview of what TB Care I is doing to help with the fight against childhood TB.

This document contains links to over 650 tools and reference materials. It is intended for national TB program staff in high burden settings who are trying to identify strategies to reach at-risk and vulnerable communities more effectively. The goal of the document is to introduce readers to the range of tools and strategies that are available in TB control.

This guide specifically addresses issues such as stigma and work discrimination, and also provides practical recommendations on how to establish an effective monitoring system.

This document includes recommendations for improving the management of children with TB and of children living in families with TB. National and regional TB control programmes may wish to adapt these recommendations according to local circumstances.

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

The purpose of this training toolkit is to build the capacity of health care workers to address and manage TB in children. The toolkit consists of ten modules. Topics include epidemiology of childhood TB, diagnosis, treatment, prevention, TB/HIV co-infection, multidrug-resistant TB, and community-based child TB management.

This booklet discusses TB in correctional facilities.

This document presents lessons learned in regards to strengthening TB care, implementing new approaches TB case detection, and increasing TB case notifications.

This handbook provides detailed examples of the analysis of TB surveillance data, in particular TB notification data, data from surveillance of anti-TB drug resistance, and mortality data compiled in national vital registration systems.

This field guide is meant to serve as a tool for practitioners working with children at risk of infection or being sick with MDR TB. It should be considered complementary to existing recommendations.